169 related articles for article (PubMed ID: 27769056)
1. Nuclear FOXO3 predicts adverse clinical outcome and promotes tumor angiogenesis in neuroblastoma.
Hagenbuchner J; Rupp M; Salvador C; Meister B; Kiechl-Kohlendorfer U; Müller T; Geiger K; Sergi C; Obexer P; Ausserlechner MJ
Oncotarget; 2016 Nov; 7(47):77591-77606. PubMed ID: 27769056
[TBL] [Abstract][Full Text] [Related]
2. C10ORF10/DEPP-mediated ROS accumulation is a critical modulator of FOXO3-induced autophagy.
Salcher S; Hermann M; Kiechl-Kohlendorfer U; Ausserlechner MJ; Obexer P
Mol Cancer; 2017 May; 16(1):95. PubMed ID: 28545464
[TBL] [Abstract][Full Text] [Related]
3. FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3.
Rupp M; Hagenbuchner J; Rass B; Fiegl H; Kiechl-Kohlendorfer U; Obexer P; Ausserlechner MJ
Oncogene; 2017 Nov; 36(44):6190-6203. PubMed ID: 28869600
[TBL] [Abstract][Full Text] [Related]
4. FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma.
Geiger K; Hagenbuchner J; Rupp M; Fiegl H; Sergi C; Meister B; Kiechl-Kohlendorfer U; Müller T; Ausserlechner MJ; Obexer P
Mol Biol Cell; 2012 Jun; 23(11):2226-34. PubMed ID: 22493319
[TBL] [Abstract][Full Text] [Related]
5. Forkhead box O3 (FoxO3) regulates kidney tubular autophagy following urinary tract obstruction.
Li L; Zviti R; Ha C; Wang ZV; Hill JA; Lin F
J Biol Chem; 2017 Aug; 292(33):13774-13783. PubMed ID: 28705935
[TBL] [Abstract][Full Text] [Related]
6. A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma.
Salcher S; Spoden G; Hagenbuchner J; Führer S; Kaserer T; Tollinger M; Huber-Cantonati P; Gruber T; Schuster D; Gust R; Zwierzina H; Müller T; Kiechl-Kohlendorfer U; Ausserlechner MJ; Obexer P
Oncogene; 2020 Jan; 39(5):1080-1097. PubMed ID: 31591479
[TBL] [Abstract][Full Text] [Related]
7. The tubulin inhibitor MG-2477 induces autophagy-regulated cell death, ROS accumulation and activation of FOXO3 in neuroblastoma.
Hagenbuchner J; Lungkofler L; Kiechl-Kohlendorfer U; Viola G; Ferlin MG; Ausserlechner MJ; Obexer P
Oncotarget; 2017 May; 8(19):32009-32026. PubMed ID: 28415610
[TBL] [Abstract][Full Text] [Related]
8. Repaglinide Silences the FOXO3/Lumican Axis and Represses the Associated Metastatic Potential of Neuronal Cancer Cells.
Salcher S; Spoden G; Huber JM; Golderer G; Lindner H; Ausserlechner MJ; Kiechl-Kohlendorfer U; Geiger K; Obexer P
Cells; 2019 Dec; 9(1):. PubMed ID: 31861249
[TBL] [Abstract][Full Text] [Related]
9. FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3.
Hagenbuchner J; Kuznetsov A; Hermann M; Hausott B; Obexer P; Ausserlechner MJ
J Cell Sci; 2012 Mar; 125(Pt 5):1191-203. PubMed ID: 22349704
[TBL] [Abstract][Full Text] [Related]
10. Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma.
Wu WR; Lin JT; Pan CT; Chan TC; Liu CL; Wu WJ; Sheu JJ; Yeh BW; Huang SK; Jhung JY; Hsiao MS; Li CF; Shiue YL
Theranostics; 2020; 10(2):707-724. PubMed ID: 31903146
[TBL] [Abstract][Full Text] [Related]
11. Loss of Forkhead Box O3 Facilitates Inflammatory Colon Cancer: Transcriptome Profiling of the Immune Landscape and Novel Targets.
Penrose HM; Cable C; Heller S; Ungerleider N; Nakhoul H; Baddoo M; Hartono AB; Lee SB; Burow ME; Flemington EF; Crawford SE; Savkovic SD
Cell Mol Gastroenterol Hepatol; 2019; 7(2):391-408. PubMed ID: 30718226
[TBL] [Abstract][Full Text] [Related]
12. SIRT3 promotion reduces resistance to cisplatin in lung cancer by modulating the FOXO3/CDT1 axis.
Cao Y; Li P; Wang H; Li L; Li Q
Cancer Med; 2021 Feb; 10(4):1394-1404. PubMed ID: 33655712
[TBL] [Abstract][Full Text] [Related]
13. Serine 574 phosphorylation alters transcriptional programming of FOXO3 by selectively enhancing apoptotic gene expression.
Li Z; Zhao J; Tikhanovich I; Kuravi S; Helzberg J; Dorko K; Roberts B; Kumer S; Weinman SA
Cell Death Differ; 2016 Apr; 23(4):583-95. PubMed ID: 26470730
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo.
Park SH; Chung YM; Ma J; Yang Q; Berek JS; Hu MC
Oncotarget; 2016 Jul; 7(27):42110-42125. PubMed ID: 27283899
[TBL] [Abstract][Full Text] [Related]
15. C10ORF10/DEPP, a transcriptional target of FOXO3, regulates ROS-sensitivity in human neuroblastoma.
Salcher S; Hagenbuchner J; Geiger K; Seiter MA; Rainer J; Kofler R; Hermann M; Kiechl-Kohlendorfer U; Ausserlechner MJ; Obexer P
Mol Cancer; 2014 Sep; 13():224. PubMed ID: 25261981
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I induces the phosphorylation and nuclear exclusion of forkhead transcription factors in human neuroblastoma cells.
Schwab TS; Madison BB; Grauman AR; Feldman EL
Apoptosis; 2005 Aug; 10(4):831-40. PubMed ID: 16133873
[TBL] [Abstract][Full Text] [Related]
17. The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival.
Obrador-Hevia A; Serra-Sitjar M; Rodríguez J; Villalonga P; Fernández de Mattos S
Br J Haematol; 2012 Feb; 156(3):334-45. PubMed ID: 22107151
[TBL] [Abstract][Full Text] [Related]
18. Forkhead box O3 promotes colon cancer proliferation and drug resistance by activating MDR1 expression.
Gao Z; Li Z; Liu Y; Liu Z
Mol Genet Genomic Med; 2019 Mar; 7(3):e554. PubMed ID: 30623608
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase SIRT6 regulates chemosensitivity in liver cancer cells via modulation of FOXO3 activity.
Hu JQ; Deng F; Hu XP; Zhang W; Zeng XC; Tian XF
Oncol Rep; 2018 Dec; 40(6):3635-3644. PubMed ID: 30542728
[TBL] [Abstract][Full Text] [Related]
20. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity.
Du WW; Fang L; Yang W; Wu N; Awan FM; Yang Z; Yang BB
Cell Death Differ; 2017 Feb; 24(2):357-370. PubMed ID: 27886165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
